Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Clinical trial NCT01456676 · COMPLETED

Trial details

NCT number

NCT01456676

Sponsor

Novartis Pharmaceuticals

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2012-01-01

Primary completion

2014-02-01

Enrollment

11

View on ClinicalTrials.gov